Pages that link to "Q43195946"
Jump to navigation
Jump to search
The following pages link to Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption (Q43195946):
Displaying 50 items.
- MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis (Q26752588) (← links)
- Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling (Q33844646) (← links)
- Effects of ω3- and ω6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. (Q33963239) (← links)
- Emerging therapies in metastatic bone pain (Q34182919) (← links)
- Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts (Q34384846) (← links)
- Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses (Q35012589) (← links)
- Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone (Q35085185) (← links)
- Type I saikosaponins a and d inhibit osteoclastogenesis in bone marrow-derived macrophages and osteolytic activity of metastatic breast cancer cells (Q35373142) (← links)
- CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts. (Q35672086) (← links)
- Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells (Q35803432) (← links)
- Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling (Q35989618) (← links)
- WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling (Q36034275) (← links)
- Ethanolic extract of Schizonepeta tenuifolia attenuates osteoclast formation and activation in vitro and protects against lipopolysaccharide-induced bone loss in vivo. (Q36109806) (← links)
- Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops (Q36333546) (← links)
- Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. (Q36511687) (← links)
- Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss. (Q36751534) (← links)
- The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway (Q37071329) (← links)
- Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. (Q37187646) (← links)
- Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway (Q37203221) (← links)
- Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities (Q37413691) (← links)
- Macrophage cathepsin K promotes prostate tumor progression in bone (Q37554550) (← links)
- Emerging therapeutic targets in breast cancer bone metastasis (Q37658767) (← links)
- Classical and neonatal Marfan syndrome mutations in fibrillin-1 cause differential protease susceptibilities and protein function. (Q38421397) (← links)
- Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy (Q38854289) (← links)
- Epithelium-Derived Wnt Ligands Are Essential for Maintenance of Underlying Digit Bone (Q39883776) (← links)
- Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model (Q40207072) (← links)
- Ferulic acid impairs osteoclast fusion and exacerbates survival of mature osteoclasts. (Q41639542) (← links)
- The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption (Q41684447) (← links)
- Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption (Q41684459) (← links)
- Magnesium vs. machined surfaced titanium - osteoblast and osteoclast differentiation (Q42723672) (← links)
- Osteoblast Hypoxia-Inducible Factor-1α Pathway Activation Restrains Osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 Pathway (Q42937988) (← links)
- BAPTA-AM, an intracellular calcium chelator, inhibits RANKL-induced bone marrow macrophages differentiation through MEK/ERK, p38 MAPK and Akt, but not JNK pathways (Q42953444) (← links)
- The Inactivation of ERK1/2, p38 and NF-kB Is Involved in the Down-Regulation of Osteoclastogenesis and Function by A2B Adenosine Receptor Stimulation (Q47109047) (← links)
- Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway. (Q47124172) (← links)
- Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity (Q47214335) (← links)
- Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signaling pathway in a rat model (Q47609765) (← links)
- Inhibitory effects of sesamin on human osteoclastogenesis (Q47730277) (← links)
- The Inhibitory Effect of Angelica tenuissima Water Extract on Receptor Activator of Nuclear Factor-Kappa-B Ligand-Induced Osteoclast Differentiation and Bone Resorbing Activity of Mature Osteoclasts (Q48079300) (← links)
- Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss. (Q48247265) (← links)
- Double Sequential Encrypted Targeting Sequence: A New Concept for Bone Cancer Treatment (Q48824485) (← links)
- Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae (Q51578494) (← links)
- Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation. (Q52779703) (← links)
- A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis. (Q52866845) (← links)
- Inhibition of Osteoclast Differentiation by Ginsenoside Rg3 in RAW264.7 Cells via RANKL, JNK and p38 MAPK Pathways Through a Modulation of Cathepsin K: An In Silico and In Vitro Study. (Q53838927) (← links)
- CA-074Me compound inhibits osteoclastogenesis via suppression of the NFATc1 and c-FOS signaling pathways. (Q55070022) (← links)
- Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts. (Q55474543) (← links)
- Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder (Q58710472) (← links)
- Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)--1H-Indol-5-Ylacetamide) on Osteoclast Differentiation via Suppressing Cathepsin K Expression (Q60928907) (← links)
- C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation (Q89701687) (← links)
- Cellular Invasion and Matrix Degradation, a Different Type of Matrix-Degrading Cells in the Cartilage of Catfish (Clarias gariepinus) and Japanese Quail Embryos (Coturnix coturnix japonica) (Q90476409) (← links)